Helius Medical Technologies Inc (HSDT) Actualités

Form 8-K - Current report

Form 8-K - Current report

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Form SD - Specialized disclosure report

Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier

-- Reimbursement at $23,900, slightly below list price -- -- Represents a significant milestone toward...

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance...

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

NEWTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or...

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or...

Form 8-K - Current report

Form 424B4 - Prospectus [Rule 424(b)(4)]

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or...